Epitomee Medical Ltd
EPTMF
$0.9892
-$0.0327-3.20%
OTC PK
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 10.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 10.00M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | 10.00M |
| SG&A Expenses | 833.00K | 971.00K | 971.00K | 971.00K | 758.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 58.00K | -- | -- | -- | 7.18M |
| Total Operating Expenses | 2.18M | 2.39M | 2.39M | 2.39M | 9.52M |
| Operating Income | -2.18M | -2.39M | -2.39M | -2.39M | 485.00K |
| Income Before Tax | -2.30M | -2.68M | -2.68M | -2.68M | 1.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.30M | -2.68M | -2.68M | -2.68M | 1.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.30M | -2.68M | -2.68M | -2.68M | 1.83M |
| EBIT | -2.18M | -2.39M | -2.39M | -2.39M | 485.00K |
| EBITDA | -2.06M | -2.29M | -2.29M | -2.29M | 538.50K |
| EPS Basic | -0.08 | -0.09 | -0.09 | -0.09 | 0.06 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.05 | -0.05 | 0.04 |
| EPS Diluted | -0.08 | -0.09 | -0.09 | -0.09 | 0.06 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.05 | -0.05 | 0.04 |
| Average Basic Shares Outstanding | 29.80M | 29.76M | 29.76M | 29.76M | 29.78M |
| Average Diluted Shares Outstanding | 29.80M | 29.76M | 29.76M | 29.76M | 29.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |